Honeywell finalizes $1.325 billion PPE business sale

Honeywell (HON) has completed the $1.325 billion cash sale of its Personal Protective Equipment (PPE) division to Protective Industrial Products, Inc. (PIP), furthering its strategic portfolio streamlining. This divestiture aligns with Honeywell's focus on core businesses like aerospace and building automation, and follows recent announcements regarding the planned separation of its Aerospace Technologies and the spin-off of its Advanced Materials business. The company's Q1 2025 earnings also exceeded expectations, with adjusted EPS of $2.51 and revenue of $9.82 billion, supported by strong performance in key segments, and analysts are largely positive on Honeywell's trajectory.

Analysis

Honeywell has advanced its portfolio optimization strategy with the completed divestiture of its Personal Protective Equipment (PPE) division to Protective Industrial Products, Inc. for $1.325 billion in cash. This move is a continuation of efforts to streamline operations and concentrate on core growth areas, following the 2021 sale of its Lifestyle and Performance Footwear Business and preceding planned separations of its Aerospace Technologies and Advanced Materials businesses. The company's strategic focus is further evidenced by its active acquisition strategy, with $13.5 billion deployed since December 2023, including businesses from Carrier Global, Civitanavi Systems, CAES Systems, Air Products, and pending deals for Sundyne and Johnson Matthey’s Catalyst Technologies. Financially, Honeywell reported strong first-quarter 2025 results, with adjusted EPS of $2.51 surpassing the $2.21 forecast, and revenue of $9.82 billion exceeding the expected $9.6 billion, driven by robust performance in its aerospace and building automation segments. This performance, coupled with a 6.27% revenue growth in the last twelve months and a 41-year history of consistent dividend payments, underpins its strategic alignment with megatrends such as automation, aviation's future, and energy transition. Analyst sentiment appears largely positive, with InvestingPro noting 13 upward earnings revisions for the upcoming period; UBS maintains a Buy rating with a $268 price target, while JPMorgan, despite raising its price target to $182 from $178, holds a Neutral rating citing valuation concerns.

Key Decisions for Investors

• Investors should view Honeywell's ongoing portfolio restructuring, including the PPE divestiture and strategic acquisitions, as a clear commitment to enhancing focus and driving growth in its core high-performing segments like aerospace and automation.
• Given the strong Q1 2025 earnings beat and positive analyst revisions, current and prospective investors might find Honeywell's transformation efforts encouraging, but should also weigh JPMorgan's valuation concerns against UBS's more bullish outlook.
• It is advisable to monitor the successful integration of newly acquired businesses and the execution of the planned spin-offs, as these will be key determinants of future shareholder value and operational efficiency.